Prostate CancerTools for Diagnosing Prostate Cancer
Frank dela Rama explains the options available today, the limitations, and possibilities in the future for the diagnosis of prostate cancer.
Video Library – March 6, 2019 Clinical Nurse Specialist,
Oncology/Genomics
CANCER CARE Palo Alto
Medical Foundation
Palo Alto, CA
Frank dela Rama explains the options available today, the limitations, and possibilities in the future for the diagnosis of prostate cancer.
Recommended For You
Prostate CancerThe PARP inhibitor Lynparza (olaparib), a type of drug that is usually used for the treatment of women with ovarian cancer, has also been studied in men with prostate cancer. The results of the PROfound clinical trial were recently presented at the 2020 ASCO annual meeting by Antoine Thiery-Vuillemin, MD, PhD, Centre Hospitalier de Besançon, France.
Prostate CancerResults of a new study showed that the combination of Cabometyx (cabozantinib) and the immune checkpoint inhibitor Tecentriq (atezolizumab) was safe and effective in men with metastatic (spreading) castration-resistant prostate cancer, the most common type of prostate cancer.
Prostate CancerHere are the drugs and financial support services available to patients receiving treatment for Prostate Cancer.
Patient AdvocacyPatient StoriesProstate CancerDennis Golden was an active, fit, 70-year-old when he learned he had prostate cancer. He was surprised to discover that few men know the warning signs and how potentially serious it can be. In response, he formed the National Prostate Cancer Awareness Foundation to educate men about this disease.
Last modified: March 19, 2019
